Cargando…

Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) cohorts often lack long-term survival data, and are summarized instead by initial treatment outcomes. When using Cox proportional hazards models to analyze these cohorts, this leads to censoring subjects at the time of the initial treatment outco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brooks, Meredith B., Keshavjee, Salmaan, Gelmanova, Irina, Zemlyanaya, Nataliya A., Mitnick, Carole D., Manjourides, Justin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290510/ https://www.ncbi.nlm.nih.gov/pubmed/30537944 http://dx.doi.org/10.1186/s12874-018-0637-0

Ejemplares similares

Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses
por: Brooks, Meredith B., et al.
Publicado: (2020)

Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru
por: Tierney, Dylan B., et al.
Publicado: (2016)

Global Financing and Long-Term Technical Assistance for Multidrug-Resistant Tuberculosis: Scaling Up Access to Treatment
por: Hwang, Thomas J., et al.
Publicado: (2014)

Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method
por: Mitnick, Carole D., et al.
Publicado: (2016)

Long-term Follow-up for Multidrug-resistant Tuberculosis
por: Shin, Sonya S., et al.
Publicado: (2006)

Protocol for a case–control study of vitamin D status, adult multidrug-resistant tuberculosis disease and tuberculosis infection in Mumbai, India
por: Mistry, Nerges, et al.
Publicado: (2020)

The need to accelerate access to new drugs for multidrug-resistant tuberculosis
por: Cox, Helen S, et al.
Publicado: (2015)

Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies
por: Hwang, Thomas J, et al.
Publicado: (2014)

Randomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis: The time for action is now
por: Mitnick, Carole D, et al.
Publicado: (2007)

Double Standards in Global Health: Medicine, Human Rights Law and Multidrug-Resistant TB Treatment Policy
por: Nicholson, Thomas, et al.
Publicado: (2016)

Extensively Drug-Resistant Tuberculosis, Lesotho
por: Satti, Hind, et al.
Publicado: (2008)

Outcomes of Comprehensive Care for Children Empirically Treated for Multidrug-Resistant Tuberculosis in a Setting of High HIV Prevalence
por: Satti, Hind, et al.
Publicado: (2012)

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2020)

Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion
por: Rodriguez, Carly A., et al.
Publicado: (2022)

A Systematic Review of Reported Cost for Smear and Culture Tests during Multidrug-Resistant Tuberculosis Treatment
por: Lu, Chunling, et al.
Publicado: (2013)

COVID-19 and Tuberculosis—A Global Tale of Hubris and Lessons Unlearned?
por: Drobniewski, Francis, et al.
Publicado: (2021)

Supporting a Comprehensive International Approach to Global Tuberculosis Eradication Is the Right Thing to Do
por: Burzynski, Joseph, et al.
Publicado: (2020)

Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis
por: Byrne, Anthony L., et al.
Publicado: (2017)

Health systems performance in managing tuberculosis: analysis of tuberculosis care cascades among high-burden and non-high-burden countries
por: Kim, Jungyeon, et al.
Publicado: (2019)

Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants
por: Odone, Anna, et al.
Publicado: (2016)

Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis
por: Fox, Gregory J., et al.
Publicado: (2016)

Multidrug-resistant Tuberculosis Management in Resource-limited Settings
por: Nathanson, Eva, et al.
Publicado: (2006)

Tuberculosis household accompaniment to improve the contact management cascade: A prospective cohort study
por: Yuen, Courtney M., et al.
Publicado: (2019)

Time to Culture Conversion and Regimen Composition in Multidrug-Resistant Tuberculosis Treatment
por: Tierney, Dylan B., et al.
Publicado: (2014)

Turning Off the Tap: Using the FAST Approach to Stop the Spread of Drug-Resistant Tuberculosis in the Russian Federation
por: Miller, Ann C, et al.
Publicado: (2018)

The Reductionist Conundrum of an “Updated” Definition of Extensively Drug-Resistant Tuberculosis
por: Mitnick, Carole D., et al.
Publicado: (2021)

Sputum culture conversion definitions and analytic practices for multidrug-resistant TB
por: Rodriguez, C. A., et al.
Publicado: (2021)

A role for community-level socioeconomic indicators in targeting tuberculosis screening interventions
por: Brooks, Meredith B., et al.
Publicado: (2022)

Geographic accessibility to health facilities predicts uptake of community-based tuberculosis screening in an urban setting
por: Jenkins, Helen E., et al.
Publicado: (2022)

Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study
por: Wang, Jianjie, et al.
Publicado: (2020)

Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation research in Peru
por: Yuen, Courtney M., et al.
Publicado: (2021)

Mapping local hot spots with routine tuberculosis data: A pragmatic approach to identify spatial variability
por: Brooks, Meredith B., et al.
Publicado: (2022)

Impact of latent tuberculosis infection on health and wellbeing: a systematic review and meta-analysis
por: Wong, Yen Jun, et al.
Publicado: (2021)

Risk-benefit analysis of tuberculosis infection testing for household contact management in high-burden countries: a mathematical modelling study
por: Yuen, Courtney M, et al.
Publicado: (2020)

Aggressive Regimens for Multidrug-Resistant Tuberculosis Decrease All-Cause Mortality
por: Mitnick, Carole D., et al.
Publicado: (2013)

Strengthening healthcare delivery with remote patient monitoring in the time of COVID-19
por: Mantena, Sreekar, et al.
Publicado: (2021)

Intervening on Social Determinants for Better Outcomes in Pediatric Tuberculosis Management
por: de Almeida, Carlos Podalirio Borges, et al.
Publicado: (2023)

Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein
por: Karthika, Chenmala, et al.
Publicado: (2022)

Survival analysis of patients with tuberculosis and risk factors for multidrug-resistant tuberculosis in Monrovia, Liberia
por: Carter, Boye Bobby, et al.
Publicado: (2021)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_o19mr1b4p3mjs5btgknhvqemvt